Carisma Therapeutics Inc.

NASDAQ: CARM · Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM

Carisma Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-60.48M -86.88M -61.23M -40.78M
Depreciation & Amortization
3.35M 2.84M 6.09M 682K
Stock-Based Compensation
3.65M 2.32M 275K 479K
Other Working Capital
-10.1M -7.63M 45.67M 2.44M
Other Non-Cash Items
5.51M 5.99M -19.65M 834K
Deferred Income Tax
n/a n/a 21.75M n/a
Change in Working Capital
-11.95M -5.44M 45.2M 1.46M
Operating Cash Flow
-59.92M -81.18M -7.57M -37.33M
Capital Expenditures
-123K -1.13M -4.66M -1.87M
Cash Acquisitions
n/a n/a 30K n/a
Purchase of Investments
n/a -34.46M -90.9M n/a
Sales Maturities Of Investments
n/a 108M 63M n/a
Other Investing Acitivies
n/a n/a -30K n/a
Investing Cash Flow
-123K 72.41M -32.56M -1.87M
Debt Repayment
-1.43M -1.3M 34.13M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-619K 32.65M -35.92M -366K
Financial Cash Flow
344K 62.18M 35.77M 15.96M
Net Cash Flow
-59.7M 53.41M -138.44M -23.24M
Free Cash Flow
-60.04M -82.31M -12.23M -39.2M